Changes in prostate-specific antigen in casodex (bicalutamide) monotherapy in a dose 150 mg/day given to patients with locally advanced and/or advanced prostatic cancer;Dinamika prostatspetsificheskogo antigena pri monoterapii kasodeksom (bikalutamidom) v doze 150 mg v den' u bol'nykh mestno-rasprostranennym i (ili) rasprostranennym rakom predstatel'noi zhelezy.

Urologiia (Moscow, Russia : 1999)

Volumn , Issue 4, 2001, Pages 26-29

  Kariakin, O B ^a   Sviridova, T V ^a   Tsodikova, L B ^a   Grishin, G N ^a   Sergeeva, T N ^a   Perekhrest, M A ^a   Donichkina, E A ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANILIDE; ANTIANDROGEN; ANTINEOPLASTIC AGENT; BICALUTAMIDE; PROSTATE SPECIFIC ANTIGEN;

ACINAR CELL CARCINOMA; ADENOCARCINOMA; AGED; ARTICLE; BLOOD; COMPARATIVE STUDY; FLUORESCENT ANTIBODY TECHNIQUE; HUMAN; MALE; METASTASIS; MIDDLE AGED; PROSTATE TUMOR; TIME;

ADENOCARCINOMA; AGED; ANDROGEN ANTAGONISTS; ANILIDES; ANTINEOPLASTIC AGENTS; CARCINOMA, ACINAR CELL; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; MALE; MIDDLE AGED; NEOPLASM METASTASIS; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; TIME FACTORS;

EID: 0035406606     PISSN: 17282985     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)